The client was preparing to commercialize a photopolymerizable resin-based composite designed for dental and bone fixation applications. Before advancing toward market launch, the client required a comprehensive Freedom-to-Operate (FTO) assessment to determine whether the proposed formulation could be manufactured and commercialized without infringing active third-party patents.
The assessment focused on jurisdictions representing key commercial markets and manufacturing interests, namely the United States, China, Germany and Japan. The challenge was determining whether any active patent broadly claimed the same combination of essential features present in the client’s product.